Product Information

BRIVIACT 10 MG TABLET is a brand product labeled by UCB, Inc., priced at $23.9520 per EA under NDC 50474037066. Its NADAC has been published 110 times since May 22, 2024.

BRIVIACT 10 MG TABLET

brivaracetam
$23.9520per EA
DEA Schedule CV

Strength

10 mg/1

Manufacturer

UCB, Inc.

NDC

50474037066

Classification

Brand

Dosage Form

TABLET, FILM COATED

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

BRIVARACETAM

Approval Type

New Drug (NDA)

FDA Application

NDA205836

On Market Since

5/12/2016

Pharmacological Classes

Epoxide Hydrolase Inhibitors

Price Statistics

The NADAC for BRIVIACT 10 MG TABLET has been published 110 times since May 22, 2024, and over the history we have for it it has risen 4.2%. The table below summarizes its recorded NADAC range and movement.

Current price$23.9520 per EA
All-time high$23.9859 (May 13, 2026)
All-time low$22.9334 (Dec 18, 2024)
52-week high$23.9859
52-week low$23.3674
Median price$23.4016
Average price$23.4209
Largest weekly change+2.6% (Jan 14, 2026)
Weeks tracked110
Tracking sinceMay 22, 2024

Price History

1W

0.0%

1M

-0.1%

3M

-0.1%

6M

+2.5%

1Y

+2.1%

3Y

N/A

5Y

N/A

All

+4.2%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the brivaracetam market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of BRIVIACT 10 MG TABLET?

The current National Average Drug Acquisition Cost (NADAC) for BRIVIACT 10 MG TABLET, manufactured by UCB, Inc., is $23.9520 per EA (NDC 50474037066), effective Jun 24, 2026.

How has the price of BRIVIACT 10 MG TABLET changed over time?

Over the history we have for it, the NADAC for BRIVIACT 10 MG TABLET has risen 4.2%. It has been tracked across 110 weekly CMS publications since May 22, 2024.

What are the highest and lowest recorded NADAC prices for BRIVIACT 10 MG TABLET?

Since May 22, 2024, the NADAC for BRIVIACT 10 MG TABLET has ranged from a low of $22.9334 (Dec 18, 2024) to a high of $23.9859 (May 13, 2026), with a median of $23.4016 per EA.

Are there cheaper alternatives to BRIVIACT 10 MG TABLET?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of BRIVIACT 10 MG TABLET, so no direct lower-cost alternative is listed.

Who manufactures BRIVIACT 10 MG TABLET?

BRIVIACT 10 MG TABLET (NDC 50474037066) is labeled by UCB, Inc., and CMS classifies it as a brand product.

Related Drugs

Same classification

No related drugs found.